Abstract
Purpose
Patients with pseudomyxoma peritonei (PMP) benefit from cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Reports on this modality usually have included only patients with successful HIPEC treatment, which can potentially cause biased results. We report the survival of a PMP population treated by CRS and HIPEC, including patients who were not eligible for HIPEC.
Methods
The outcome of the whole population of 87 patients with PMP treated by CRS and HIPEC in Helsinki University Central Hospital between 2008 and 2011 was evaluated. The results of treatment were compared with 33 patients treated by serial debulking in our unit between 1984 and 2008.
Results
Of the 87 patients in the HIPEC-era group, 56 received HIPEC, 12 were treated non-radically in an attempt at HIPEC, 9 were debulked and 10 were referred back or transferred to palliative care without surgery. The 5-year overall survival for the debulking-era group and the HIPEC-era group were 67 and 69 %, respectively. The number of patients with no evidence of disease was higher in the HIPEC-era group (47/87) than that in the debulking-era group (8/33) at the end of the follow-up. Overall survival for patients who underwent successful CRS and HIPEC at 2 and 5 years was 95 and 93 %, respectively.
Conclusions
The improved survival from using the CRS and HIPEC was not apparent after 5-year follow-up, when the whole patient population was included in the analysis. Even so, patients successfully treated by CRS and HIPEC manage well.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 34(2):196–201. doi:10.1016/j.ejso.2007.04.002
Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ (2008) Pseudomyxoma peritonei. Curr Probl Surg 45(8):527–575. doi:10.1067/j.cpsurg.2008.04.003
Jarvinen P, Jarvinen HJ, Lepisto A (2010) Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis Off J Assoc Coloproctology Great Brit Irel 12(9):868–872. doi:10.1111/j.1463-1318.2009.01947.x
Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens JM, O’Brien PC, van Heerden JA (1994) Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 219(2):112–119
Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG (2005) Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241(2):300–308
Moran B, Baratti D, Yan TD, Kusamura S, Deraco M (2008) Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98(4):277–282. doi:10.1002/jso.21054
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gomez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, Gonzalez-Moreno S, Van Der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 30(20):2449–2456. doi:10.1200/JCO.2011.39.7166
Jarvinen P, Ristimaki A, Kantonen J, Lepisto A (2013) Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc 102(3):145–151. doi:10.1177/1457496913490463
Bosman FT CF, Hruban RH, Theise ND (eds) (2010) WHO classification of tumours of the digestive system, 4th edn. IARC, Lyon
Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42
Sugarbaker PH (2004) Carcinomatosis from gastrointestinal cancer. Ann Med 36(1):9–22
Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6(8):727–731
Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6(8):790–796
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Andreasson H, Graf W, Nygren P, Glimelius B, Mahteme H (2012) Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38(10):962–968. doi:10.1016/j.ejso.2012.07.009
Acknowledgments
This study was supported by a grant from the Finnish Medical Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Järvinen, P., Ristimäki, A., Kantonen, J. et al. Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin. Int J Colorectal Dis 29, 999–1007 (2014). https://doi.org/10.1007/s00384-014-1933-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-014-1933-8